Julie Roques
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Neuroblastoma Research and Treatments, Cancer Genomics and Diagnostics, Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma(2015)454 cited
- → Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions(2017)395 cited
- → Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness(2016)206 cited
- → Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts(2017)195 cited
- → Basal‐like and classical cells coexist in pancreatic cancer revealed by single‐cell analysis on biopsy‐derived pancreatic cancer organoids from the classical subtype(2020)143 cited
- → LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker(2017)105 cited
- → TNF-α induces endothelial–mesenchymal transition promoting stromal development of pancreatic adenocarcinoma(2021)90 cited
- → A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma(2020)81 cited
- → Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer(2020)80 cited
- → A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis(2021)42 cited